|
KMID : 0578320180410120993
|
|
Molecules and Cells
2018 Volume.41 No. 12 p.993 ~ p.999
|
|
|
BC200 RNA: An Emerging Therapeutic Target and Diagnostic Marker for Human Cancer
|
|
Shin Hee-Gwon
Kim Young-Mi
Kim Meehyein
Lee Young-Hoon
|
|
|
Abstract
|
|
|
|
One of the most interesting findings from genome-wide expression analysis is that a considerable amount of noncoding RNA (ncRNA) is present in the cell. Recent studies have identified diverse biological functions of ncRNAs, which are expressed in a much wider array of forms than proteins. Certain ncRNAs associated with diseases, in particular, have attracted research attention as novel therapeutic targets and diagnostic markers. BC200 RNA, a 200-nucleotide ncRNA originally identified as a neuron-specific transcript, is abnormally over-expressed in several types of cancer tissue. A number of recent studies have suggested mechanisms by which abnormal expression of BC200 RNA contributes to the development of cancer. In this article, we first provide a brief review of a recent progress in identifying functions of BC200 RNA in cancer cells, and then offer examples of other ncRNAs as new therapeutic targets and diagnostic markers for human cancer. Finally, we discuss future directions of studies on BC200 RNA for new cancer treatments.
|
|
|
KEYWORD
|
|
|
BC200 RNA, cancer, diagnostic marker, ncRNA (noncoding RNA), therapeutic target
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|